Your session is about to expire
← Back to Search
Contrast-Enhanced Ultrasound for Renal Cell Carcinoma
N/A
Waitlist Available
Led By Anil Kapoor, MD, FRCSC
Research Sponsored by St. Joseph's Healthcare Hamilton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
at least 18 years of age and capable of giving informed consent
patient undergoing CT of MRI for monitoring of renal lesions after radiofrequency ablation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months post radiofrequency ablation
Awards & highlights
Study Summary
This trial is investigating whether contrast-enhanced ultrasound (CEUS) can be an effective tool for follow-up monitoring of kidney cancer patients who have undergone radiofrequency ablation (RFA), by comparing the results of their standard follow-up CT scans (or MRIs if applicable) with the results of CEUS.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months post radiofrequency ablation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months post radiofrequency ablation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cognitive Therapy
Secondary outcome measures
Quality of life data
Trial Design
1Treatment groups
Experimental Treatment
Group I: Contrast-Enhanced UltrasoundExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
St. Joseph's Healthcare HamiltonLead Sponsor
195 Previous Clinical Trials
25,394 Total Patients Enrolled
McMaster UniversityOTHER
877 Previous Clinical Trials
2,596,030 Total Patients Enrolled
Anil Kapoor, MD, FRCSCPrincipal InvestigatorMcMaster University
3 Previous Clinical Trials
240 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger